At the moment, all available platelets are donor derived which is an unsustainable resource especially at times of crises when the demand for platelets surges. Add to this a short 7-day shelf life and it’s no surprise we are always at the brink of a shortage. The New Platelet Company wants to address this bottleneck by providing a stem-cell derived universal platelet product that can be stockpiled and deployed on demand.